Maintenance of therapeutically active levels of isoniazid for prolonged periods in rabbits after a single implant of biodegradable polymer

Kilpatrick, 1987, Compliance in relation to tuberculosis, Tubercle, 68, 31, 10.1016/S0041-3879(87)80018-1 Fox, 1983, Compliance of patients and physicians: experience and lessons from tuberculosis, BMJ, 287, 33, 10.1136/bmj.287.6384.33 Fox, 1983, Compliance of patients and physicians: experience and lessons from tuberculosis, BMJ, 287, 101, 10.1136/bmj.287.6385.101 Gangadharam, 1991, Sustained release of isoniazid in vivo from a single implant of a biodegradable polymer, Tubercle, 72, 115, 10.1016/0041-3879(91)90038-T Gangadharam, 1989, Sustained release of isoniazid in vivo from a biodegradable polymer implant, 54 Gangadharam, 1993, Release of isoniazid for prolonged periods from a biodegradable polymer under several in vitro and simulated in vivo conditions and in animals, J Control Release, 26, 87, 10.1016/0168-3659(93)90108-H Gangadharam, 1994, Experimental chemotherapy of tuberculosis using single dose treatment with isoniazid in biodegradable polymer, J Antimicro Chemother, 33, 265, 10.1093/jac/33.2.265 Gangadharam, 1993, Sustained release of pyrazinamide from a single implant of a biodegradable polymer Kailasam, 1994, Biovailability of clofazimine in vivo for prolonged period following a single implant of a biodegradable polymer, J Antimicro Chemother, 33, 273, 10.1093/jac/33.2.273 Hutchings, 1983, High performance liquid chromatographic analysis of isoniazid and acetylisoniazid in biological materials, J. Chromatogr, 227, 385, 10.1016/S0378-4347(00)84863-X Siddiqi, 1981, Evaluation of a rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis, J Clin Microbiol, 13, 908, 10.1128/JCM.13.5.908-912.1981